Clinical Trials Logo

Filter by:
NCT ID: NCT04467346 Completed - Clinical trials for Therapeutic Equivalency

Bioequivalence Study Between Temozolomide Oral Suspension (Ped-TMZ) and Temodal® Capsules

Start date: September 25, 2020
Phase: Phase 1
Study type: Interventional

Primary objective: • Evaluate bioequivalence between Temozolomide Oral Suspension and Temodal® capsules for oral administration. Secondary objectives: - Define the pharmacokinetic parameters of Temozolomide Oral Suspension. - Assess the buccal safety of Temozolomide Oral Suspension.

NCT ID: NCT04467008 Completed - Covid19 Clinical Trials

Covid-19 Rapid Diagnostic Tests on Blood Drop

COVID-TEST
Start date: July 15, 2020
Phase:
Study type: Observational

This study will evaluate the diagnostic reliability of the Biosynex rapid blood test for Covid-19 infection.

NCT ID: NCT04466839 Completed - Parkinson Disease Clinical Trials

Evaluation of the Containment Impact Linked to the Covid-19 Pandemic in a Population of Parkinson Patients

ERCO-Park
Start date: July 2, 2020
Phase:
Study type: Observational

The consequences of COVID-19 in these already fragile patients should be evaluated. It will be important to appreciate the confinement consequences imposed on the patient on the course and impact of the disease. These consequences can be assessed by the end of confinement and 6 months after the latter is lifted.

NCT ID: NCT04466800 Completed - COVID Clinical Trials

Functional and Respiratory Rehabilitation and Nutritional Care of COVID-19 Patients (RECOVER-19)

RECOVER-19
Start date: July 30, 2020
Phase: N/A
Study type: Interventional

Following the acute phase of COVID, some patients may have sequelae, such as breathing difficulties or malnutrition. We hypothesize that a functional and respiratory rehabilitation program associated with personalized nutritional care will improve quality of life, physical performance and respiratory capacities and will decrease the prevalence of malnutrition among those patients.

NCT ID: NCT04465773 Completed - Pain Clinical Trials

Pupillary Response to Incremental Tetanic Stimulations Under Propofol-remifentanil TCI

Start date: January 2012
Phase: N/A
Study type: Interventional

In patients under standardized steady-state general anesthesia, 6 tetanic stimulations of incremental intensities were applied to the patients. Pupillary dilation in response to these stimulations was recorded.

NCT ID: NCT04465331 Completed - Knee Osteoarthritis Clinical Trials

Adaptation and Validation of the Exercise Adherence Rating Scale of Knee Osteoarthritis Patients (GONEARS)

GONEARS
Start date: December 30, 2019
Phase:
Study type: Observational

The origin of knee osteoarthritis is multifactorial but the disease is strongly related to age. The pain and functional disability are the main reasons for consultation. Non-pharmaceutical treatment is always indicated. The rehabilitation will reduce the pain, maintain or partially recover the amplitude of the movements as well as fight against vicious analgesic attitudes and strengthen the muscles to stabilize the joints. A program of self-rehabilitation exercises performed at home may be prescribed to people with knee osteoarthritis. It must include exercises adapted to the patient's functional abilities and painful level and requires education to improve the patient's motivation to practice a regular exercise program. However, adherence to such exercises is low, and until 2016 there was no objective way to find out the reasons for patients' lack of adherence to self-workout programs. The EARS ("Exercise Adherence Rating Scale" or Adhesion to Physical Exercise Programs) is validated in 2016 and reliable to evaluate the physical activity of patients with low back pain. As far as we know, this questionnaire is the only one validated in the international literature, a validation for French patients is currently underway. We believe this tool can be used for patients with knee osteoarthritis after minor changes.

NCT ID: NCT04465084 Completed - Language Disorders Clinical Trials

Assessment of Language Disorders in Multiple Sclerosis Patients

LANSEP
Start date: August 17, 2020
Phase: N/A
Study type: Interventional

Multiple sclerosis (MS) is an autoimmune disease of the central nervous systems that results in focal inflammatory lesions and then diffuse and degenerative inflammatory phenomena. It is considered to be the leading cause of non-traumatic disability in young adults. Cognitive impairment is a common and disabling part of MS. Studies carried out in the years 1990-2000 estimated their frequency to be between 40 and 60% of MS patients: they reflect the natural history of the disease. Effective treatments for the inflammatory component of the disease that are now available may have led to a reduction in their frequency. Cognitive disorders were identified at an early stage of the disease and affect certain areas preferentially: - The most common achievement is the reduction in the speed of information processing. It is present from the early stage of the disease. Progressive deterioration over time is observed, which is a prognostic factor for long-term cognitive decline. Long-term memory was impaired in 40-65% of patients in historical cohorts. More specifically, encoding and retrieval were affected, with storage and consolidation being preserved. - The attainment of executive functions is also common. - Phonemic and semantic fluency are also disturbed in MS patients. Among cognitive impairments, language impairment has been little studied in MS: in 2016 only 22 controlled studies were identified. The assessments carried out were most often partial, making it impossible to define the characteristics or to conclude that specific linguistic impairments are independent of other cognitive impairments. Finally, recent studies suggest that the frequency of language impairment in MS may be underestimated. Therefore, it seems important to assess the prevalence of language disorders in a large cohort of patients with RRMS or MS, and to characterize these disorders by identifying the linguistic processes involved and the brain substrates involved. This will make it possible to envisage the implementation of more systematic screening for language disorders in MS and to improve patient management, in particular by developing targeted rehabilitation protocols.

NCT ID: NCT04465045 Completed - Clinical trials for Unexplained Infertility

Unexplained Infertility Treated by Hysteroscopy-laparoscopy

Start date: June 1, 2020
Phase:
Study type: Observational

Retrospective study, including patients from january 2013 to december 2018, who were diagnosed with unexplained infertility : spontaneously ovulating women with normal pelvic ultrasound scan, patent tubes on hysterosalpingography and normal pelvic exam or pelvic MRI normal. Semen analyses were normal according to the World Health Organization criteria. Couples were referred for diagnostic laparoscopy and hysteroscopy. They were then addressed for spontaneous fertility or ART to conceive. The investigators would like to see how many surgeries were useful to assess a diagnostic, and if operating allows a satisfying pregnancy rate. The investigators would like to assess how many diagnosis was done after surgery and how many pregnancy were obtained. The investigators search other prognostic factors than age or parity.

NCT ID: NCT04464824 Completed - Emergencies Elderly Clinical Trials

Study of the Preventable Passage of Patients Over 75 Years of Age to the Emergency Room of the CHRU of Nancy

PE75UN
Start date: January 1, 2020
Phase:
Study type: Observational

The adult emergency service of the Nancy CHRU welcomes an average of 135 visits per day. Approximately 18% are patients over 75 years old, among them 45% go home at the end of their care. The mobile geriatric liaison team intervenes with these patients at the request of the emergency doctors before they return home in order to identify their fragility and implement appropriate measures. We wish to know the characteristics of these avoidable passages in order to propose preventive measures upstream of these passages. To do this, we need to know the characteristics of those patients with an avoidable passage.

NCT ID: NCT04464252 Completed - Clinical trials for Orthognathic Surgery

Development and Validation of an Automated Three-dimensional Cephalometry Method

AutoCEPH-3D
Start date: April 30, 2022
Phase:
Study type: Observational

This study is aimed to develop and assess the validity of an algorithm for automated three-dimensional cephalometry.